A novel copper(II) mononuclear complex with the non-steroidal anti-inflammatory drug diclofenac: Structural characterization and biological activity

A copper(II) complex with the non-steroidal anti-inflammatory drug (NSAID) diclofenac has been for the first time synthesized and characterized without any co-organic ligand. Its biological activity against four human cell lines underlined a higher activity of the monomeric complex than the parent molecule in the case of tumoral cell lines. A ternary Cu-diclofenac-albumin complex was suspected to be the reactive species in biological medium.

A copper(II) complex with the non-steroidal anti-inflammatory drug (NSAID) diclofenac has been for the first time synthesized and characterized without any co-organic ligand. Its biological activity against four human cell lines underlined a higher activity of the monomeric complex than the parent molecule in the case of tumoral cell lines.Figure optionsDownload as PowerPoint slideHighlights
► Novel copper(II) complex containing the non-steroidal anti-inflammatory drug diclofenac was synthesized and characterized.
► The complex was obtained as a mononuclear species without co-organic ligand.
► The monomeric complex showed a significant biological activity against human cell lines.
► The complex underlined a higher activity than the parent molecule in the case of tumoral cell lines.